LBO — BAPTIST MEDICAL CTR-NASSAU
IRR: 34.3% | MOIC: 4.37x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
34.3%
IRR
4.37x
MOIC
$18.2M
Entry EV
$49.7M
Exit EV
$9.4M
Equity Invested
Sources & Uses
S&UTotal · $18.2M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $7.1M | 38.8% | |
| Sub Debt | $1.8M | 9.7% | |
| Equity | $9.4M | 51.5% | |
| Enterprise Value | $17.6M | 97.1% | |
| Transaction Fees | $0.5M | 2.9% | |
| Total Uses | $18.2M | 100.0% |
Interpretation
INTAt 4.37x MOIC and 34.3% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $4.7M |
| Exit Ev | $49.7M |
| Net Debt At Exit | $8.8M |
| Equity At Exit | $40.9M |
| Equity Invested | $9.4M |
| Total Value Created | $31.5M |
| Value From Growth | $31.2M |
| Value From Multiple | $0.9M |
| Value From Deleveraging | 0.0% |